Premier Path Wealth Partners’s Roivant Sciences ROIV Stock Holding History

Premier Path Wealth Partners’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$425K	Hold	12,000	–	–	0.05%	297
2026 Q1	$332K	Hold	12,000	–	–	0.04%	332
2025 Q4	$260K	Hold	12,000	–	–	0.03%	351
2025 Q3	$182K	Hold	12,000	–	–	0.02%	390
2025 Q2	$135K	Hold	12,000	–	–	0.02%	383
2025 Q1	$121K	Hold	12,000	–	–	0.02%	370
2024 Q4	$142K	Hold	12,000	–	–	0.02%	366
2024 Q3	$138K	Hold	12,000	–	–	0.02%	362
2024 Q2	$127K	Hold	12,000	–	–	0.02%	364
2024 Q1	$126K	Buy	+12,000	New	+$129K	0.02%	339

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Premier Path Wealth Partners's ROIV Position: Q2 2026 in Review

Premier Path Wealth Partners held its Roivant Sciences (ROIV) position steady in Q2 2026 at 12,000 shares worth $425K. The position accounts for 0.05% of the portfolio, ranked #297.

Premier Path Wealth Partners first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Premier Path Wealth Partners held 12,000 shares of Roivant Sciences worth $425K as of Q2 2026.
Premier Path Wealth Partners left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 0.05% of Premier Path Wealth Partners's portfolio in Q2 2026, its #297 holding.
Premier Path Wealth Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.